IRLAB Therapeutics AB (publ) (STO: IRLAB.A)
Sweden
· Delayed Price · Currency is SEK 14.00
-0.40 (-2.78%)
Sep 2, 2024, 10:51 AM CET
IRLAB Therapeutics AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 33 | 62 | 71 | 58.1 | -0.6 | 44.2 | Upgrade
|
| Depreciation & Amortization | 75 | 94 | 78 | 57.3 | 56.4 | 62.2 | Upgrade
|
| Other Amortization | - | - | - | 7 | 2 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -8.5 | Upgrade
|
| Asset Writedown & Restructuring Costs | 21 | 21 | - | - | - | - | Upgrade
|
| Other Operating Activities | -49 | -45 | -17 | 7.3 | -4 | 23.6 | Upgrade
|
| Change in Accounts Receivable | - | - | - | 4.6 | 27.3 | -22.4 | Upgrade
|
| Change in Inventory | -25 | 50 | -190 | -56.5 | 19.4 | 23.1 | Upgrade
|
| Change in Other Net Operating Assets | 17 | -29 | 5 | 23.3 | 17.6 | -26.5 | Upgrade
|
| Operating Cash Flow | 72 | 153 | -53 | 101.1 | 118.1 | 101.4 | Upgrade
|
| Operating Cash Flow Growth | 26.32% | - | - | -14.39% | 16.47% | -37.45% | Upgrade
|
| Capital Expenditures | -4 | -15 | -38 | -110.1 | -91.1 | -82.2 | Upgrade
|
| Sale of Property, Plant & Equipment | -2 | - | 12 | 82.1 | 50.5 | 99.2 | Upgrade
|
| Cash Acquisitions | -12 | -50 | -123 | -110.7 | - | -11.3 | Upgrade
|
| Sale (Purchase) of Intangibles | -5 | -8 | -17 | -15.4 | -4.7 | -6.1 | Upgrade
|
| Investment in Securities | -3 | - | 7 | 20.5 | 39.9 | -30.7 | Upgrade
|
| Other Investing Activities | -1 | -1 | 1 | - | - | -28 | Upgrade
|
| Investing Cash Flow | -27 | -74 | -158 | -133.6 | -5.4 | -59.1 | Upgrade
|
| Long-Term Debt Issued | - | 17 | 328 | 80.6 | - | 90 | Upgrade
|
| Total Debt Issued | 315 | 17 | 328 | 80.6 | - | 90 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.1 | -39.8 | Upgrade
|
| Long-Term Debt Repaid | - | -23 | -4 | -41 | -118.5 | -139.3 | Upgrade
|
| Total Debt Repaid | -332 | -23 | -4 | -41 | -118.6 | -179.1 | Upgrade
|
| Net Debt Issued (Repaid) | -17 | -6 | 324 | 39.6 | -118.6 | -89.1 | Upgrade
|
| Common Dividends Paid | -23 | -22 | -21 | - | - | -13.6 | Upgrade
|
| Other Financing Activities | -1 | -27 | -100 | - | - | - | Upgrade
|
| Financing Cash Flow | -41 | -55 | 203 | 39.6 | -118.6 | -102.7 | Upgrade
|
| Foreign Exchange Rate Adjustments | -3 | -3 | - | - | - | - | Upgrade
|
| Net Cash Flow | 1 | 21 | -8 | 7.1 | -5.9 | -60.4 | Upgrade
|
| Free Cash Flow | 68 | 138 | -91 | -9 | 27 | 19.2 | Upgrade
|
| Free Cash Flow Growth | 1600.00% | - | - | - | 40.63% | -81.99% | Upgrade
|
| Free Cash Flow Margin | 6.62% | 11.62% | -7.79% | -1.04% | 4.59% | 2.41% | Upgrade
|
| Free Cash Flow Per Share | 2.45 | 4.99 | -3.29 | -0.33 | 0.99 | 0.70 | Upgrade
|
| Cash Interest Paid | 25 | 25 | 9 | 10 | 21.2 | 6.5 | Upgrade
|
| Cash Income Tax Paid | 9 | 13 | 18 | 11.8 | 0.8 | 2.2 | Upgrade
|
| Levered Free Cash Flow | - | 54.75 | -21.78 | -40.74 | 25.65 | -11.84 | Upgrade
|
| Unlevered Free Cash Flow | - | 70.38 | -14.28 | -37.24 | 27.53 | -7.71 | Upgrade
|
| Change in Net Working Capital | - | 75 | 100.4 | 21.1 | -59.8 | 22.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.